Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

Accelerating Cell Line Development

| Brett Verstak | 5 min read

The essential roles of optimized cell lines and vectors in accelerating bioprocessing.

Manufacture Technology and Equipment

The Benefits of AI and Automation in the Lab

| Hansjoerg Haas | 3 min read

Welcome to the labs of the future, with increased efficiency with robotics and automation, and new insights powered by AI and machine learning.

Manufacture Bioprocessing - Upstream & Downstream

Just – Evotec Biologics Expands in Europe

Find out more about a new continuous manufacturing facility opened by Just – Evotec Biologics in Toulouse, France.

Manufacture Bioprocessing - Upstream & Downstream

UK Government Bolsters Support for Life Sciences

| Rob Coker

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

Manufacture Bioprocessing - Upstream & Downstream

Celebrating a Decade in Bioprocessing

Dive into our top articles in biopharma and bioprocessing, from the promise of X-ray sterilization to the challenges of space-based biomanufacturing.

Manufacture Bioprocessing - Upstream & Downstream

Genetic Tailoring With CRISPR

| Cillian McGorman | 4 min read

How CRISPR can change the way we design and produce antibodies.

Business & Regulation Business Practice

Who Are the Best Pharma Companies of 2025?

Voting is now open for our 2025 Company of the Year Awards.

Manufacture Bioprocessing - Upstream & Downstream

Optimizing mRNA Sequence Design

| Claes Gustafsson | 4 min read

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

Manufacture Bioprocessing - Upstream & Downstream

From Big Pharma to Non-Profit

| 6 min read

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

Manufacture Advanced Medicine

Integrated Expertise

| 7 min read

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register